Login / Signup

Evaluation of Long-Term Outcomes of Direct Acting Antiviral Agents in Chronic Kidney Disease Subjects: A Single Center Cohort Study.

Paulina CzarneckaKinga CzarneckaOlga TroninaTeresa BaczkowskaAleksandra Wyczałkowska-TomasikMagdalena DurlikKatarzyna Czerwinska
Published in: Journal of clinical medicine (2023)
DAAs provide a safe and effective cure for CHC in both CKD patients and KTRs with a favorable safety profile in the long-term follow-up.
Keyphrases
  • end stage renal disease
  • chronic kidney disease
  • ejection fraction
  • newly diagnosed
  • prognostic factors
  • peritoneal dialysis
  • patient reported outcomes